Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.12 is 88% below its 5-year average of 1.04, near the low end of its 5-year range (0.00–5.09).
As of the fiscal period ended Friday, July 31, 2026. 88.94% below its 12-month average of 1.10.
Reported quarterly current ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 0.12.
CURRENT RATIO
0.12
CURRENT RATIO AVG TTM
1.10
CURRENT RATIO AVG 3Y
1.86
CURRENT RATIO AVG 5Y
1.04
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-88.94%
CURRENT VS 3Y AVG
-93.45%
CURRENT VS 5Y AVG
-88.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 616 covered companies
CURRENT VS SECTOR MEDIAN
-96.41%
vs the sector median at left
Market Cap
$7.83M
Current Ratio
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$8.17M
Current Ratio
13.55
TTM Avg
6.32
3Y Avg
6.80
5Y Avg
6.83
Market Cap
$7.28M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$8.48M
Current Ratio
0.60
TTM Avg
0.62
3Y Avg
0.79
5Y Avg
1.04
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $7.86M | 0.12 | 1.10 | 1.86 | 1.04 |
| GT Biopharma, Inc. (GTBP)vs › | $7.84M | 2.61 | 2.11 | 2.42 | 2.17 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.96M | 7.10 | 3.48 | 3.83 | 5.25 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | 5.86 | 2.71 | 2.06 | 3.31 |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.17M | 13.55 | 6.32 | 6.80 | 6.83 |
| DataMEDS AI, Inc. (MEDS)vs › | $8.30M | 0.14 | 0.24 | 0.20 | 0.20 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.28M | 45.95 | 58.73 | 40.89 | 40.89 |
| KALA BIO, Inc. (KALA)vs › | $7.22M | 6.88 | 3.46 | 4.15 | 4.60 |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.48M | 0.60 | 0.62 | 0.79 | 1.04 |
| Longeveron Inc. (LGVN)vs › | $7.42M | 2.63 | 4.46 | 3.65 | 4.69 |
Current Ratio
0.12
Quick Ratio
-71.42
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-07-31 | 0.12 |
| 2026-04-30 | 0.50 |
| 2026-01-31 | 1.00 |
| 2025-10-31 | 2.42 |
| 2025-07-31 | 1.47 |
| 2025-04-30 | 0.59 |
| 2025-01-31 | 1.02 |
| 2024-10-31 | 1.72 |
| 2024-07-31 | 4.49 |
| 2024-04-30 | 4.20 |
| 2024-01-31 | 5.09 |
| 2023-10-31 | 0.51 |
| 2023-07-31 | 1.07 |
| 2023-04-30 | 1.47 |
| 2023-01-31 | 1.45 |
| 2022-10-31 | 1.31 |
| 2022-07-31 | 3.53 |
| 2022-04-30 | 0.56 |
| 2022-01-31 | 0.00 |
| 2021-10-31 | 0.00 |
| 2021-07-31 | 0.00 |
| 2021-04-30 | 1.47 |
